Aerosol exposure to the angola strain of marburg virus causes lethal viral hemorrhagic fever in cynomolgus macaques

Veterinary Pathology

Volumn 47, Issue 5, 2010, Pages 831-851

  Alves, D A ^a   Glynn, A R ^a   Steele, K E ^a   Lackemeyer, M G ^a   Garza, N L ^a   Buck, J G ^a   Mech, C ^a   Reed, Douglas S ^b  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

aerosol; animal model; Marburg virus; nonhuman primate

Indexed keywords

CYTOKINE;

ANIMAL; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE; BODY TEMPERATURE; DISEASE MODEL; EXPOSURE; FEMALE; HEART RATE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER; LUNG; LYMPH NODE; MACACA FASCICULARIS; MALE; MARBURG HEMORRHAGIC FEVER; MARBURG VIRUS; PATHOLOGY; SPLEEN; VIREMIA; VIROLOGY;

ANIMALS; BLOOD CELL COUNT; BLOOD PRESSURE; BODY TEMPERATURE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HEART RATE; HUMANS; IMMUNOHISTOCHEMISTRY; INHALATION EXPOSURE; LIVER; LUNG; LYMPH NODES; MACACA FASCICULARIS; MALE; MARBURG VIRUS DISEASE; MARBURGVIRUS; SPLEEN; VIREMIA;

ANIMALIA; LAKE VICTORIA MARBURGVIRUS; MACACA; MARBURGVIRUS; PRIMATES;

EID: 78649293543     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810378597     Document Type: Article

References (93)

1. Alibek K., Handelman S.: Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World, Told From the Inside by the Man Who Ran It. Random House, New York, NY, 1999.
2. Anderson AO, Anderson ND: Studies on the structure and permeability of the microvasculature in normal rat lymph nodes. Am J Pathol 80:387-418, 1975.
3. Anderson ND, Anderson AO, Wyllie RG: Specialized structure and metabolic activities of high endothelial venules in rat lymphatic tissues. Immunology 31:455-473, 1976.
4. Baize S., Leroy EM, Georges AJ, Georges-Courbot MC, Capron M., Bedjabaga I., Lansoud-Soukate J., Mavoungou E.: Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 128:163-168., 2002.
5. Baron RC, McCormick JB, Zubeir OA: Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 61:997-1003, 1983.
6. Baskerville A., Bowen ET, Platt GS, McArdell LB, Simpson DI: The pathology of experimental Ebola virus infection in monkeys. J Pathol 125:131-138, 1978.
7. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, Borchert M., Rollin PE, Sleurs H., Campbell P., Tshioko FK, Roth C., Colebunders R., Pirard P., Mardel S., Olinda LA, Zeller H., Tshomba A., Kulidri A., Libande ML, Mulangu S., Formenty P., Grein T., Leirs H., Braack L., Ksiazek T., Zaki S., Bowen MD, Smit SB, Leman PA, Burt FJ, Kemp A., Swanepoel R.: Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 355:909-919, 2006.
8. Belanov EF, Muntianov VP, Kriuk VD, Sokolov AV, Bormotov NI, P'Iankov OV, Sergeev AN: [Survival of Marburg virus infectivity on contaminated surfaces and in aerosols]. Vopr Virusol 41:32-34, 1996.
9. Bente D., Gren J., Strong JE, Feldmann H.: Disease modeling for Ebola and Marburg viruses. Dis Model Mech 2:12-17, 2009.
10. Borio L., Inglesby T., Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, Ksiazek T., Johnson KM, Meyerhoff A., O'Toole T., Ascher MS, Bartlett J., Breman JG, Eitzen EM Jr, Hamburg M., Hauer J., Henderson DA, Johnson RT, Kwik G., Layton M., Lillibridge S., Nabel GJ, Osterholm MT, Perl TM, Russell P., Tonat K.: Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287:2391-2405, 2002.
11. Bosio CM, Aman MJ, Grogan C., Hogan R., Ruthel G., Negley D., Mohamadzadeh M., Bavari S., Schmaljohn A.: Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 188:1630-1638, 2003.
12. Bray M., Davis K., Geisbert T., Schmaljohn C., Huggins J.: A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 179:S248-S258, 1999.
13. Bukreev AA, Skripchenko AA, Gusev Iu M., Frolov VG, Kandrushin EV, Krasnitskaia IM, Shestopalov AM: [A promising method for preparative production and purification of the Marburg virus]. Vopr Virusol 40:161-165, 1995.
14. Bukreyev AA, Volchkov VE, Blinov VM, Dryga SA, Netesov SV: The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: a comparison with the Musoke (1980) strain. Arch Virol 140:1589-1600, 1995.
15. Bwaka MA, Bonnet MJ, Calain P., Colebunders R., De Roo A., Guimard Y., Katwiki KR, Kibadi K., Kipasa MA, Kuvula KJ, Mapanda BB, Massamba M., Mupapa KD, Muyembe-Tamfum JJ, Ndaberey E., Peters CJ, Rollin PE, Van den Enden E.: Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 179:S1-S7, 1999.
16. Centers for Disease Control and Prevention: Outbreak of Marburg virus hemorrhagic fever: Angola, October 1, 2004-March 29, 2005. MMWR Morb Mortal Wkly Rep 54:308-309, 2005.
17. Centers for Disease Control and Prevention: Update: outbreak of Ebola viral hemorrhagic fever. Zaire, 1995. MMWR Morb Mortal Wkly Rep 44:468-469, 475, 1995.
18. Clark SL Jr: The reticulum of lymph nodes in mice studied with the electron microscope. Am J Anat 110:217-257, 1962.
19. Connolly BM, Steele KE, Davis KJ, Geisbert TW, Kell WM, Jaax NK, Jahrling PB: Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis 179:S203-S217, 1999.
20. Daddario-DiCaprio KM, Geisbert TW, Geisbert JB, Stroher U., Hensley LE, Grolla A., Fritz EA, Feldmann F., Feldmann H., Jones SM: Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J Virol 80:9659-9666, 2006.
21. Daddario-DiCaprio KM, Geisbert TW, Stroher U., Geisbert JB, Grolla A., Fritz EA, Fernando L., Kagan E., Jahrling PB, Hensley LE, Jones SM, Feldmann H.: Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet 367:1399-1404, 2006.
22. Dalgard DW, Hardy RJ, Pearson SL, Pucak GJ, Quander RV, Zack PM, Peters CJ, Jahrling PB: Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys. Lab Anim Sci 42:152-157, 1992.
23. Davis KJ, Anderson AO, Geisbert TW, Steele KE, Geisbert JB, Vogel P., Connolly BM, Huggins JW, Jahrling PB, Jaax NK: Pathology of experimental Ebola virus infection in African green monkeys: involvement of fibroblastic reticular cells. Arch Pathol Lab Med 121:805-819, 1997.
24. Dietrich M., Schumacher HH, Peters D., Knobloch J.: Human pathology of Ebola (Maridi) virus infection in the Sudan. In: Ebola Virus Haemorrhagic Fever, ed. Pattyn SR, pp. 37-42. Elsevier / North-Holland Biomedical Press, New York, 1978.
25. Dowell SF, Mukunu R., Ksiazek TG, Khan AS, Rollin PE, Peters CJ: Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179:S87-S91, 1999.
26. Ellis DS, Simpson IH, Francis DP, Knobloch J., Bowen ET, Lolik P., Deng IM: Ultrastructure of Ebola virus particles in human liver. J Clin Pathol 31:201-208, 1978.
27. Fisher-Hoch SP, Brammer TL, Trappier SG, Hutwagner LC, Farrar BB, Ruo SL, Brown BG, Hermann LM, Perez-Oronoz GI, Goldsmith CS: Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. J Infect Dis 166:753-763, 1992.
28. Fisher-Hoch SP, Platt GS, Neild GH, Southee T., Baskerville A., Raymond RT, Lloyd G., Simpson DI: Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J Infect Dis 152:887-894, 1985.
29. Food and Drug Administration: New drug and biological drug products: evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule. Fed Regist 67:37988-37998, 2002.
30. Fritz EA, Geisbert JB, Geisbert TW, Hensley LE, Reed DS: Cellular immune response to Marburg virus infection in cynomolgus macaques. Viral Immunol 21:355-363, 2008.
31. Frolov VG, Gusev Iu M.: [Stability of Marburg virus to lyophilization process and subsequent storage at different temperatures]. Vopr Virusol 41:275-277, 1996.
32. Geisbert TW, Daddario-Dicaprio KM, Geisbert JB, Reed DS, Feldmann F., Grolla A., Stroher U., Fritz EA, Hensley LE, Jones SM, Feldmann H.: Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine 26:6894-6900, 2008.
33. Geisbert TW, Daddario-DiCaprio KM, Geisbert JB, Young HA, Formenty P., Fritz EA, Larsen T., Hensley LE: Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J Infect Dis 196:S372-S381, 2007.
34. Geisbert TW, Hensley LE, Larsen T., Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E., Jahrling PB, Davis KJ: Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 163:2347-2370, 2003.
35. Geisbert TW, Jahrling PB: Exotic emerging viral diseases: progress and challenges. Nat Med 10:S110-S121, 2004.
36. Gibb TR, Bray M., Geisbert TW, Steele KE, Kell WM, Davis KJ, Jaax NK: Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J Comp Pathol 125:233-242, 2001.
37. Gretz JE, Anderson AO, Shaw S.: Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol Rev 156:11-24, 1997.
38. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S.: Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med 192:1425-1440, 2000.
39. Haas R., Maass G., Muller J., Oehlert W.: [Experimental infection of cercopithecus aethiops with the agent of the Frankfut-Marburg syndrome (FMS)]. Z Med Mikrobiol Immunol 154:210-220, 1968.
40. Hartings JM, Roy CJ: The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates. J Pharmacol Toxicol Methods 49:39-55, 2004.
41. Hevey M., Negley D., Pushko P., Smith J., Schmaljohn A.: Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology 251:28-37, 1998.
42. Jaax N., Jahrling P., Geisbert T., Geisbert J., Steele K., McKee K., Nagley D., Johnson E., Jaax G., Peters C.: Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 346:1669-1671, 1995.
43. Jaax NK, Davis KJ, Geisbert TJ, Vogel P., Jaax GP, Topper M., Jahrling PB: Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 120:140-155, 1996.
44. Jahrling PB, Geisbert TW, Dalgard DW, Johnson ED, Ksiazek TG, Hall WC, Peters CJ: Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 335:502-505, 1990.
45. Johnson E., Jaax N., White J., Jahrling P.: Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 76:227-236, 1995.
46. Johnson ED, Johnson BK, Silverstein D., Tukei P., Geisbert TW, Sanchez AN, Jahrling PB: Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl 11:101-114, 1996.
47. Karttunen T., Sormunen R., Risteli L., Risteli J., Autio-Harmainen H.: Immunoelectron microscopic localization of laminin, type IV collagen, and type III pN-collagen in reticular fibers of human lymph nodes. J Histochem Cytochem 37:279-286, 1989.
48. Komai-Koma M., Xu D., Li Y., McKenzie AN, McInnes IB, Liew FY: IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 37:2779-2786, 2007.
49. Kramer RH, Rosen SD, McDonald KA: Basement-membrane components associated with the extracellular matrix of the lymph node. Cell Tissue Res 252:367-375, 1988.
50. Kuchler AM, Pollheimer J., Balogh J., Sponheim J., Manley L., Sorensen DR, De Angelis PM, Scott H., Haraldsen G.: Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol 173:1229-1242, 2008.
51. LeDuc JW: Epidemiology of hemorrhagic fever viruses. Rev Infect Dis 11:S730-S735, 1989.
52. Leffel EK, Reed DS: Marburg and Ebola viruses as aerosol threats. Biosecur Bioterror 2:1-6, 2004.
53. Leroy EM, Baize S., Debre P., Lansoud-Soukate J., Mavoungou E.: Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol 124:453-460, 2001.
54. Lub M., Sergeev AN, P'Iankov OV, P'Iankova OG, Petrishchenko VA, Kotliarov LA: [Certain pathogenetic characteristics of a disease in monkeys in infected with the Marburg virus by an airborne route]. Vopr Virusol 40:158-161, 1995.
55. Lub M., Sergeev AN, P'Iankova OG, P'Iankov OV, Petrishchenko VA, Kotliarov LA: [Clinical-virusological characteristics of disease in guinea pigs, infected by the Marburg virus aerogenically]. Vopr Virusol 40:119-121, 1995.
56. Martini GA, Schmidt HA: [Spermatogenic transmission of the "Marburg virus": causes of "Marburg simian disease"]. Klin Wochenschr 46:398-400, 1968.
57. Martini GA, Siegert R.: Marburg Virus Disease, p. 230. Springer-Verlag, Berlin, Germany, 1971.
58. Miranda ME, Ksiazek TG, Retuya TJ, Khan AS, Sanchez A., Fulhorst CF, Rollin PE, Calaor AB, Manalo DL, Roces MC, Dayrit MM, Peters CJ: Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis 179:S115-S119, 1999.
59. Miranda ME, Yoshikawa Y., Manalo DL, Calaor AB, Miranda NL, Cho F., Ikegami T., Ksiazek TG: Chronological and spatial analysis of the 1996 Ebola Reston virus outbreak in a monkey breeding facility in the Philippines. Exp Anim 51:173-179, 2002.
60. Moe RE: The structure of the reticulum and sinuses of lymph nodes. Am J Anat 112:311-335, 1963.
61. Mohamadzadeh M.: Potential factors induced by filoviruses that lead to immune supression. Curr Mol Med 9:174-185, 2009.
62. Moussion C., Ortega N., Girard JP: The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel "alarmin"? PLoS One 3:e3331, 2008.
63. Mueller SN, Germain RN: Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 9:618-629, 2009.
64. Olah I., Rohlich P., Toro S.: Ultrastructure of Lymphoid Organs. JB Lippincott, Philadelphia, PA, 1975.
65. P'Iankov OV, Sergeev AN, P'Iankova OG, Chepurnov AA: [Experimental Ebola fever in Macaca mulatta]. Vopr Virusol 40:113-115, 1995.
66. Reed DS, Lackemeyer MG, Garza NL, Norris S., Gamble S., Sullivan LJ, Lind CM, Raymond JL: Severe encephalitis in cynomolgus macaques exposed to aerosolized eastern equine encephalitis virus. J Infect Dis 196:441-450, 2007.
67. Rippey JJ, Schepers NJ, Gear JH: The pathology of Marburg virus disease. S Afr Med J 66:50-54, 1984.
68. Rowe AK, Bertolli J., Khan AS, Mukunu R., Muyembe-Tamfum JJ, Bressler D., Williams AJ, Peters CJ, Rodriguez L., Feldmann H., Nichol ST, Rollin PE, Ksiazek TG: Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo: Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179:S28-S35, 1999.
69. Rubins KH, Hensley LE, Wahl-Jensen V., Daddario DiCaprio KM, Young HA, Reed DS, Jahrling PB, Brown PO, Relman DA, Geisbert TW: The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol 8:R174, 2007.
70. Ryabchikova E., Strelets L., Kolesnikova L., Pyankov O, Sergeev A: Respiratory Marburg virus infection in guinea pigs. Arch Virol 141:2177-2190, 1996.
71. Ryabchikova EI, Kolesnikova LV, Luchko SV: An analysis of features of pathogenesis in two animal models of Ebola virus infection. J Infect Dis 179:S199-S202, 1999.
72. Ryabchikova EI, Kolesnikova LV, Netesov SV: Animal pathology of filoviral infections. Curr Top Microbiol Immunol 235:145-173, 1999.
73. Sadek RF, Khan AS, Stevens G., Peters CJ, Ksiazek TG: Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis 179:S24-S27, 1999.
74. Sanada S., Hakuno D., Higgins LJ, Schreiter ER, McKenzie AN, Lee RT: IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117:1538-1549, 2007.
75. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan TK, Zurawski G., Moshrefi M., Qin J., Li X., Gorman DM, Bazan JF, Kastelein RA: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479-490, 2005.
76. Shu HL, Siegert R., Slenczka W.: The pathogenesis and epidemiology of the "Marburg-virus" infection. Ger Med Mon 14:7-10, 1969.
77. Siegert R., Shu HL, Slenczka W.: [Isolation and identification of the "Marburg virus"]. Dtsch Med Wochenschr 93:604-612, 1968.
78. Slenczka WG: The Marburg virus outbreak of 1967 and subsequent episodes. Curr Top Microbiol Immunol 235:49-75, 1999.
79. Smith DH, Johnson BK, Isaacson M., Swanapoel R., Johnson KM, Killey M., Bagshawe A., Siongok T., Keruga WK: Marburg-virus disease in Kenya. Lancet 1:816-820, 1982.
80. Steele K., Crise B., Kuehne A., Kell W.: Ebola virus glycoprotein demonstrates differential cellular localization in infected cell types of nonhuman primates and guinea pigs. Arch Pathol Lab Med 125:625-630, 2001.
81. Steele KE, Anderson AO, Mohamadzadeh M.: Fibroblastic reticular cells and their role in viral hemorrhagic fevers. Expert Rev Anti Infect Ther 7:423-435, 2009.
82. Stenman S., Vaheri A.: Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J Exp Med 147:1054-1064, 1978.
83. Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, Bawiec DA, Hartman AL, Comer JA, Zaki SR, Stroher U., Gomes da Silva F., Del Castillo F., Rollin PE, Ksiazek TG, Nichol ST: Marburgvirus genomics and association with a large hemorrhagic Fever outbreak in angola. J Virol 80:6497-6516, 2006.
84. Tykocinski M., Schinella RA, Greco MA: Fibroblastic reticulum cells in human lymph nodes: an ultrastructural study. Arch Pathol Lab Med 107:418-422, 1983.
85. van den Berg TK, van der Ende M., Dopp EA, Kraal G, Dijkstra CD: Localization of beta 1 integrins and their extracellular ligands in human lymphoid tissues. Am J Pathol 143:1098-1110, 1993.
86. Villinger F., Rollin PE, Brar SS, Chikkala NF, Winter J., Sundstrom JB, Zaki SR, Swanepoel R., Ansari AA, Peters CJ: Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 179:S188-S191, 1999.
87. Viral haemorrhagic fever/Marburg, Democratic Republic of the Congo. Wkly Epidemiol Rec 74:157-158, 1999.
88. Warfield KL, Alves DA, Bradfute SB, Reed DK, VanTongeren S., Kalina WV, Olinger GG, Bavari S.: Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virol J 4:108, 2007.
89. Warfield KL, Bradfute SB, Wells J., Lofts L., Cooper MT, Alves DA, Reed DK, VanTongeren SA, Mech CA, Bavari S.: Development and characterization of a mouse model for Marburg hemorrhagic fever. J Virol 83:6404-6415, 2009.
90. Warfield KL, Swenson DL, Olinger GG, Nichols DK, Pratt WD, Blouch R., Stein DA, Aman MJ, Iversen PL, Bavari S.: Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog 2:e1, 2006.
91. Wenk EJ, Orlic D., Reith EJ, Rhodin JA: The ultrastructure of mouse lymph node venules and the passage of lymphocytes across their walls. J Ultrastruct Res 47:214-241, 1974.
92. Zaki SR, Goldsmith CS: Pathologic features of Filovirus infections in humans. Curr Top Microbiol Immunol 235:97-116, 1999.
93. Zaki SR, Shieh WJ, Greer PW, Goldsmith CS, Ferebee T., Katshitshi J., Tshioko FK, Bwaka MA, Swanepoel R., Calain P., Khan AS, Lloyd E., Rollin PE, Ksiazek TG, Peters CJ: A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever: Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179:S36-S47, 1999.